Journal article
Impact of histology and toxicities on outcomes of patients with muscle invasive bladder cancer receiving neoadjuvant chemotherapy.
Abstract
540
Background: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) extends survival in muscle invasive bladder cancer (MIBC) patients (pts). Pathologic complete response (pCR) is associated with survival. We conducted a retrospective study to examine the prognostic impact of other variables including histologic subtype, location, multifocality, margins, size of tumor and toxicities. Methods: Pts …
Authors
Curran C; Pond GR; Acosta A; Nassar A; Abou Alaiwi S; Ingham MD; Preston MA; Steele GS; Kilbridge KL; McGregor BA
Journal
Journal of Clinical Oncology, Vol. 38, No. 6_suppl, pp. 540–540
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 20, 2020
DOI
10.1200/jco.2020.38.6_suppl.540
ISSN
0732-183X